PP
NVO

Pingora Partners’s Novo Nordisk NVO Stock Holding History

Pingora Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$66.2K Buy
1,800
+1,360
+309% +$64.4K 0.04% 117
2025
Q4 		$22.4K Buy
440
+200
+83% +$10.2K 0.01% 161
2025
Q3 		$13.3K Hold
240
– – 0.01% 175
2025
Q2 		$16.6K Hold
240
– – 0.01% 167
2025
Q1 		$16.7K Buy
240
+50
+26% +$4.13K 0.01% 168
2024
Q4 		$16.3K Hold
190
– – 0.01% 182
2024
Q3 		$22.6K Hold
190
– – 0.02% 170
2024
Q2 		$27.1K Hold
190
– – 0.02% 165
2024
Q1 		$24.4K Buy
+190
New +$22.6K 0.02% 180

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Pingora Partners's NVO Position: Q1 2026 in Review

Pingora Partners increased its Novo Nordisk (NVO) stake by 309% in Q1 2026, buying an estimated $64.4K and bringing the position to 1,800 shares worth $66.2K. The position accounts for 0.04% of the portfolio, ranked #117.

Pingora Partners first reported a position in NVO in Q1 2024 and has held it in 9 quarters since. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Pingora Partners held 1,800 shares of Novo Nordisk worth $66.2K as of Q1 2026.
  • Pingora Partners bought 1,360 Novo Nordisk shares in Q1 2026, an estimated $64.4K.
  • Novo Nordisk made up 0.04% of Pingora Partners's portfolio in Q1 2026, its #117 holding.
  • Pingora Partners first reported a position in Novo Nordisk in Q1 2024 and has held it in 9 quarters since.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Pingora Partners's 13F filing for Q1 2026, filed 15 May 2026.